Lupin’s Q1 2023 results show a 16% profit growth and expanding margins, with revenue exceeding Rs 8,200 crore. Know the key highlights and what they mean for th
Category: Pharmaceuticals
Lupin Q1 Results: Profit Surges 16% as Margins Expand
Lupin’s Q1 results show a 16% profit growth with revenue surpassing Rs 8,200 crore, highlighting the company’s expansion in the pharmaceutical industry.
Gates Medical Research Institute, Serum Institute Partner to Manufacture Groundbreaking TB Vaccine
The Gates Medical Research Institute and Serum Institute of India collaborate to develop and manufacture a novel TB vaccine. Discover the latest advancements in
Sun Pharma to Acquire US-Listed Organon in $12 Billion Deal
Sun Pharmaceutical Industries Ltd., an Indian multinational pharmaceutical company, is set to acquire US-listed Organon & Co. in a massive $12 billion deal that
